Sarah Feldkamp, MD

University of Cincinnati
Cincinnati, OH

Disclosures:

Presentations

Sep 29

1024 - Phase I Study of Hypofractionated Whole Pelvis Radiation in Endometrial Cancer Using a Novel Patient-Reported Outcomes Continual Reassessment Method (PRO-CRM)
05:05pm - 05:10pm PT
Sep 30

3430 - Hepatobiliary Toxicity Following Ablative Radiation for Centrally Located Hepatocellular Carcinoma (HCC)
Hall F
02:30pm - 03:45pm PT